iSpecimen Inc. (ISPC): auditor change — iSpecimen auditor Wolf & Company resigns; Bush & Associates appointed as new independent auditor

iSpecimen Inc.

Wolf & Company resigned as iSpecimen's auditor effective March 7, 2025.
Audit reports for FY2022 and FY2023 were unqualified; FY2023 included a going-concern explanatory paragraph.
No disagreements or reportable events between company and Wolf during those periods.
Audit Committee appointed Bush & Associates CPA LLC as new auditor on March 10, 2025 for FY2024.
No consultations with Bush & Associates on accounting principles or audit matters prior to appointment.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

iSpecimen Inc. engaged Bush & Associates CPA LLC as its auditor.

Action: engagement
Auditor: Bush & Associates CPA LLC

Exact text from the filing

On March 10, 2025, following the approval of the Audit Committee of the Company’s Board of Directors, the Company appointed Bush & Associates CPA LLC (“Bush & Associates”) as its new independent registered public accounting firm to serve as the Company’s auditor for the fiscal year ending December 31, 2024.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Wolf & Company, P.C. resigned as auditor of iSpecimen Inc..

Action: resignation
Auditor: Wolf & Company, P.C.
Successor: Bush & Associates CPA LLC

Exact text from the filing

On March 7, 2025, iSpecimen Inc. (the “Company”) was notified that Wolf & Company, P.C. (“Wolf & Company”) resigned as the Company’s independent registered public accounting firm, effective immediately.

View on SEC.gov

19 auditor changes filed in the last 30 days. Browse all auditor changes →

iSpecimen Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-022444

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.